The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Murugan Amar since 2021.
This trader's CIK number is 1809916.
At the time of last reporting, Murugan Amar was the Chief Legal Officer of Acelyrin, Inc.. (stock ticker symbol SLRN).
Also see all insider trading activities at Acelyrin, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | SLRN | 0 | $0 | 3,913 | $10,737 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | ATRA | 0 | $0 | 33,559 | $27,668 | 0 | $0 |
2023 | ATRA | 0 | $0 | 29,589 | $49,954 | 0 | $0 |
2022 | ATRA | 0 | $0 | 12,842 | $76,020 | 0 | $0 |
2021 | ATRA | 0 | $0 | 9,885 | $145,080 | 0 | $0 |
2. Atara Biotherapeutics, Inc. (ATRA)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-03-17 | SLRN | Sale | 3,913 | 2.74 | 10,737 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-08-16 | ATRA | Sale | 1,158 | 6.63 | 7,677 |
2024-05-16 | ATRA | Sale | 32,401 | .62 | 19,991 |
2023-11-16 | ATRA | Sale | 8,307 | .39 | 3,231 |
2023-08-16 | ATRA | Sale | 8,672 | 1.65 | 14,326 |
2023-05-16 | ATRA | Sale | 8,389 | 2.04 | 17,088 |
2023-03-02 | ATRA | Sale | 4,221 | 3.63 | 15,309 |
2022-11-16 | ATRA | Sale | 3,612 | 4.49 | 16,217 |
2022-08-16 | ATRA | Sale | 3,430 | 5.03 | 17,266 |
2022-05-17 | ATRA | Sale | 3,223 | 5.32 | 17,136 |
2022-03-01 | ATRA | Sale | 2,577 | 9.86 | 25,401 |
2021-11-16 | ATRA | Sale | 2,124 | 17.12 | 36,356 |
2021-08-17 | ATRA | Sale | 2,080 | 12.53 | 26,066 |
2021-05-18 | ATRA | Sale | 5,681 | 14.55 | 82,658 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Murugan Amar (Chief Legal Officer of Acelyrin, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.